Abstract: The invention relates to an expandable bead comprising a) a polyolefin selected from polyethylene (PE), polypropylene (PP) and mixtures thereof and b) thermoplastic microspheres encapsulating a blowing agent.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: In some embodiments, systems, apparatuses, and methods are provided herein useful to calculating and presenting information related to effectiveness of a promotion. In some embodiments, a system comprises a POS system configured to collect sales data for products, a display device configured to present the information related to the effectiveness of the promotion, and a control circuit configured to receive the sales data for products, determine actual sales for a product, calculate baseline sales for the product, calculate halo sales of the affined product, calculate cannibalized sales, calculate one or more of return sales and lost sales, calculate, based on one or more of the actual sales for the product, the baseline sales for the product, the halo sales, the cannibalized sales, the return sales, and the lost sales, a net lift, and present, via the display device, and indication of the net lift.

Abstract: The disclosure describes systems and methods for performing additive manufacturing. The method includes forming a first layer of a product on a target surface, heating a portion of the first layer with a directed energy source, and forming a second layer of the product on the first layer. The system for performing additive manufacturing includes a vacuum chamber, a target surface disposed in the vacuum chamber, a first layer of material formed on the target surface, a directed energy source configured to heat a portion of the first layer, and a second layer of material formed on the heated portion of the first layer.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: A method at a user equipment including detecting that a circuit switched (CS) call has been requested at the user equipment; if a most recent registration attempt or registration update attempt with a network of a first radio access technology (RAT) resulted in an abnormal state, registering with a network of a second RAT; and initiating the CS call with the network of the second RAT.

Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.

Abstract: A slug mitigation system for subsea pipelines includes a riser located between a low level and an upper (above sea-) level of a pipeline, where an inline separator, e.g. an “I-SEP”, is located upstream of a first stage separator. A throttling valve or fixed restriction is located downstream or upstream in series with the inline separator. Further aspects may also include a surface jet pump upstream of the in-line separator and/or a cyclonic separator downstream of the in-line separator.

Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.

Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.

Abstract: A passenger seat mounting system adaptable for various and changing mobile technology is provided. The universal mounting system has an enclosure and a universal bracket assembly for securing to the various and changing mobile technology. The enclosure defines an enclosure cavity for said mobile technology, wherein the universal bracket assembly operatively engages the mobile technology through rear cutouts of the enclosure so that all three components are removably secured. The universal mounting system may be pivotally connected to supporting legs that are adapted to slide into standard head rest holes of a seat body. As the universal bracket assembly is adjustable, so are the varieties of mobile technology that can be universally mounted.

Abstract: A slug mitigation system for subsea pipelines includes a riser located between a low level and an upper (above sea-) level of a pipeline, where an inline separator, e.g. an “I-SEP”, is located upstream of a first stage separator. A throttling valve or fixed restriction is located downstream or upstream in series with the inline separator. Further aspects may also include a surface jet pump upstream of the in-line separator and/or a cyclonic separator downstream of the in-line separator.

Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.

Abstract: A cementitious composition includes at least one cementitious material, at least one aggregate, from about 0.2% by weight to about 5% by weight of at least one superplasticizer, and from about 0.1% by weight to about 5% by weight of at least one water retention agent. The composition, upon mixing with an aqueous component, has an initial viscosity of no greater than about 150,000 cps, and a 20 minute viscosity of no less than about 250,000 cps.

Abstract: A system and method for multi-stage injection in a transfer molding system. Some exemplary embodiments may be a method used in a transfer molding system comprising compressing a molding compound, injecting a center portion of the compressed molding compound into a mold, and then injecting an outer portion of the compressed molding compound into the mold.

Abstract: A medical device for drug delivery is provided which includes a stent structure and a biologically active structure attached to the stent structure. The biologically active structure is comprised of a plurality of layers, including a first layer having a first biologically active compound, such as an anti-proliferative, cytostatic or cytotoxic drug, for delivery at a first target site, such as the vascular tissue; a second layer having a second biologically active compound, such as a growth factor, for delivery into the arterial lumen and capable of promoting engraftment and differentiation of hematopoietic stem cells and/or endothelial progenitor cells at a second site of myocardial injury; and a third, middle layer which is substantially or selectively impermeable to both the first and second biologically active compounds.